Germany First As Pfenex And Alvogen Biosimilar Forsteo Is Launched

MA Holder Theramex Has Plans For More EU Countries

After launching in the US last year, the teriparatide product developed by Pfenex and Alvogen has been introduced in Europa, via commercialization partner Theramex, beginning with Germany.

Business People Shaking Hands With Flag of Germany
More major EU countries will follow Germany, Theramex said. • Source: Shutterstock

More from Biosimilars

More from Products